NO20072328L - Farmasoytisk preparat for behandling av tare- og salivavaeske-torking - Google Patents

Farmasoytisk preparat for behandling av tare- og salivavaeske-torking

Info

Publication number
NO20072328L
NO20072328L NO20072328A NO20072328A NO20072328L NO 20072328 L NO20072328 L NO 20072328L NO 20072328 A NO20072328 A NO 20072328A NO 20072328 A NO20072328 A NO 20072328A NO 20072328 L NO20072328 L NO 20072328L
Authority
NO
Norway
Prior art keywords
tare
treatment
pharmaceutical preparation
saliva fluid
fluid drying
Prior art date
Application number
NO20072328A
Other languages
English (en)
Norwegian (no)
Inventor
Yohei Okada
Ken Ikeda
Fumikazu Wanibuchi
Keiichi Yoshihara
Hiromu Kondo
Hiroyuki Kojima
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of NO20072328L publication Critical patent/NO20072328L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20072328A 2004-10-05 2007-05-04 Farmasoytisk preparat for behandling av tare- og salivavaeske-torking NO20072328L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004292611 2004-10-05
PCT/JP2005/018310 WO2006038596A1 (ja) 2004-10-05 2005-10-04 涙液及び唾液乾燥症治療用医薬組成物

Publications (1)

Publication Number Publication Date
NO20072328L true NO20072328L (no) 2007-06-29

Family

ID=36142669

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072328A NO20072328L (no) 2004-10-05 2007-05-04 Farmasoytisk preparat for behandling av tare- og salivavaeske-torking

Country Status (15)

Country Link
US (2) US20070105934A1 (zh)
EP (1) EP1712230A1 (zh)
JP (1) JPWO2006038596A1 (zh)
KR (1) KR20070061578A (zh)
CN (1) CN101031297A (zh)
AU (1) AU2005290532A1 (zh)
BR (1) BRPI0516468A (zh)
CA (1) CA2582615A1 (zh)
IL (1) IL182124A0 (zh)
MX (1) MX2007003994A (zh)
NO (1) NO20072328L (zh)
RU (1) RU2007116944A (zh)
TW (1) TW200616628A (zh)
WO (1) WO2006038596A1 (zh)
ZA (1) ZA200702784B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090082381A1 (en) * 2005-07-26 2009-03-26 Akiharu Isowaki Percutaneously Absorbable Ophthalmic Preparation
US10338203B2 (en) 2011-09-09 2019-07-02 Siemens Medical Solutions Usa, Inc. Classification preprocessing in medical ultrasound shear wave imaging
JP6526475B2 (ja) * 2015-04-30 2019-06-05 サンスター株式会社 経皮唾液腺投与用の唾液分泌促進剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2683783B2 (ja) * 1992-07-10 1997-12-03 雪印乳業株式会社 シェーグレン症候群治療剤
ATE219933T1 (de) * 1992-09-18 2002-07-15 Yamanouchi Pharma Co Ltd Hydrogelzubereitung mit verzögerter freisetzung
JPH07126163A (ja) * 1993-10-08 1995-05-16 Theratech Inc 制御放出性ピロカルピン送達システム
US6528529B1 (en) * 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
US20020142033A1 (en) * 1998-05-05 2002-10-03 Gupta Suneel K. Method for treating incontinence
US20020028240A1 (en) * 2000-04-17 2002-03-07 Toyohiro Sawada Timed-release compression-coated solid composition for oral administration
JP2003063964A (ja) * 2001-08-28 2003-03-05 Senju Pharmaceut Co Ltd ドライアイまたはドライアイを伴なう疾病の予防治療剤

Also Published As

Publication number Publication date
TW200616628A (en) 2006-06-01
CN101031297A (zh) 2007-09-05
US20070105934A1 (en) 2007-05-10
US20080131511A1 (en) 2008-06-05
EP1712230A1 (en) 2006-10-18
AU2005290532A1 (en) 2006-04-13
MX2007003994A (es) 2007-06-15
KR20070061578A (ko) 2007-06-13
CA2582615A1 (en) 2006-04-13
ZA200702784B (en) 2008-09-25
WO2006038596A1 (ja) 2006-04-13
RU2007116944A (ru) 2008-11-20
BRPI0516468A (pt) 2008-09-09
IL182124A0 (en) 2007-07-24
JPWO2006038596A1 (ja) 2008-05-15

Similar Documents

Publication Publication Date Title
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
NO20075323L (no) Ernaeringspreparat for HIV-pasienter
EP2526933A3 (en) Inhibitors of bruton's tyrosine kinase
EE200100505A (et) Modifitseeritud tärklise kasutamine hüdrofiilses kontrollitud vabanemisega preparaadis, hüdrofiilnekontrollitud vabanemisega preparaat, selle valmistamismeetod ja kasutamine ning ravimvorm
NO20073059L (no) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
WO2007113851A3 (en) Novel compositions for hair disorders and process of preparation thereof
TNSN01053A1 (fr) Compositions nouvelles comprenant un agoniste partiel des recepteurs de nicotine et un agent analgesique
WO2006105193A3 (en) Personal care compositions with color changing indicator
MX2010003258A (es) Utilizacion de un nuevo agente natural en composiciones cosmeticas.
MX2009001711A (es) Formulaciones de liberacion sostenida de topiramato.
MXPA06001815A (es) Preparado farmaceutico transdermico que contiene combinaciones de principios activos para el tratamiento de la enfermedad de parkinson.
BRPI0602329A (pt) composição de cuidados orais, dispositivos e métodos de uso das mesmas
DE60024491D1 (de) Schnell-wirkende, gefrier-trocknete, orale, pharmazeutische formulierung für die behandlung von migräne
NO20055766L (no) Positive modulatorer av nikotinacetylcholinreseptorer
NO982006L (no) Terapeutisk preparat for transdermal tilf°rsel av virksomme stoffer gjennom huden
ATE350377T1 (de) Substituierte 3-pyrrolidin-indol-derivate
TR200201250T2 (tr) Hidroksieikosatetraenoat tuzları, bileşimleri ve bunların göz kuruması bozukluklarının iyileştirilmesinde kullanım yöntemleri.
WO2005079750A3 (en) Films for use as dosage forms
NO20072328L (no) Farmasoytisk preparat for behandling av tare- og salivavaeske-torking
BRPI0411324A (pt) composições farmacêuticas e métodos de tratamento de resposta mediada por histamina em pacientes
SE9902597D0 (sv) New use
EA200801890A1 (ru) Средство для лечения шума в ушах
PL1874410T3 (pl) Odbarwiająca lub rozjaśniająca kompozycja kosmetyczna zawierająca co najmniej jedną oksazolinę jako składnik aktywny
DE60213464D1 (de) Amlopidinbezylat-tabletten mit verbesserter stabilität
NO985695L (no) Formulering og fremgangsmÕte for Õ behandle kongestiv hjerteinfarkt

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application